Axcelis Technologies (NASDAQ:ACLS) designs, manufactures and services capital equipment for the semiconductor manufacturing industry. Its principle offerings include ion implantation systems, dry strip equipment, thermal processing systems, cleaning devices and curing systems. Most of the largest chip makers in the world are on its client list.
The firm pleased investors last week, when it guided Q4 EPS to 11-15 cents (12 cent consensus) and Q4 revenues to $115-$125 million
($121.2M consensus). The CEO remarked that orders for both the implant and dry strip products were high in Q4. She also noted that increasing momentum in sales of the new single wafer Optima HD implant system is bolstering the company's prospects for 2007. ACLS shares popped through stout moving average resistance on the news and then began formation of a bullish "flag" consolidation pattern. Stocks frequently exit a flag with a move in the same direction they were traveling when they entered it. In this case, that would be to the upside. Note that the 90-day moving average curve is currently supporting the flag.
Brokers recommend the issue with one "strong buy", four "buys", seven "holds" and two "sells". Analysts see a 15 percent annual average growth rate, through the next five years. The stock's Price to Sales ratio (1.56), Price to Book ratio (1.47), Price to Cash Flow ratio (15.04), Sales Growth rate (40.50%) and EPS Growth (-0.02 to 0.12 yr/yr) compare favorably with industry, sector and S&P 500 averages.
The stock is one of those used to calculate the S&P 600 SmallCap Index. Institutional investors hold about 94 percent of the outstanding shares. Over the past 52 weeks, ACLS has traded between $5.16 and $8.20. A stop-loss of $5.80 looks good here. Note that the firm is expected to report Q4 results on January 31st, after the closing bell.
Larry Schutts is a contributing editor for Theflyonthewall.com and the Vice-President of Stockwinners.com.